Evidence map›Paper›PMID 38708693›Full record

ArticleJournal of primary care & community health

Determination of COVID-19 Late Disorders as Possible Long-COVID and/or Vaccination Consequences.

Mona Sadat Larijani, Anahita Bavand, Mohammad Banifazl, Fatemeh Ashrafian, Ladan Moradi, Amitis Ramezani

Abstract read
In one paragraph

Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Persistent CD19Frontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mona Sadat LarijaniClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Anahita BavandClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Mohammad BanifazlIranian Society for Support of Patients With Infectious Disease, Tehran, Iran.
Fatemeh AshrafianClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Ladan MoradiClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Amitis RamezaniClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.ORCID 0000-0003-3502-8524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this era in which the vast majority of the global population have developed COVID-19 infection and/or got vaccinated against it, identification of the late disorders as the vaccines' side effect or long-COVID manifestation seems essential. This study included the vaccinated individuals of 4 different vaccine regimens including inactivated virus-based, subunit protein, and adenovirus-based vaccines in a follow-up schedule 6-month post the booster shot. All the documented vaccine adverse events were thoroughly assessed considering the cases' medical history by Adverse Events Committee of Pasteur Institute of Iran. Totally 329 individuals who got 3 doses of vaccination were followed 6 months after the booster shots among whom 41 (12.4%) cases with the mean age of 40.9 ± 10.48 years had a type of disorder. Gynecological and osteoarticular involvements were the most common recorded disorders of which 73.1% were possibly linked to vaccination outcomes and the rest were affected by both long-COVID-19 and vaccination. Notably, the average time of symptoms persistence was 155 ± 10.4 days. This study has the advantage of long-term follow-up which presents various forms of late events in each episode of COVID-19 infection and vaccination. About 26.8% of people with persistent complications suffered from both long-COVOD/ vaccination in whom the differentiation between the vaccine side effect and long-COVID manifestation was quite challenging. Long-term follow-up studies in large population seems essential to outline the role of long-COVID and vaccination regarding persistent complications.

Indexed as

COVID-19COVID-19 VaccinesPost-Acute COVID-19 SyndromeAdultFemaleHumansImmunization, SecondaryIranMaleMiddle AgedSARS-CoV-2VaccinationCOVID-19 Vaccineslate AEslong-COVIDlong-term disorderslong-VAXvaccine outcome

Identifiers

PMID38708693
PMCPMC11075438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.